Predose Forced Expiratory Flow Between 25% and 75% (FEF25-75%) in Inhaled Corticosteroid (ICS)-Dependent Patients With Mild to Moderate or Moderate to Severe Persistent Asthma Receiving Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI)